Why lyophilized peptides are shipped dry
Lyophilization, or freeze-drying, removes water from a frozen sample by sublimation under vacuum. The result is a dry cake or powder, sometimes a barely visible film at the bottom of the vial, and it exists for one reason: peptides are considerably more stable dry than in solution.
In solution, a peptide is exposed to hydrolysis, oxidation, aggregation and microbial growth. Removing the water suspends most of that chemistry. A lyophilized peptide stored correctly can remain stable for years. The same peptide in aqueous solution at room temperature may degrade measurably in days.
Everything that follows exists to manage the transition between those two states as carefully as possible, and to limit the time spent in the less stable one.
Handling the vial before it is opened
Vials arriving cold should be brought to room temperature before opening. This is not a formality. A cold vial opened in a warm room draws in humid air, and water condenses onto the lyophilizate. That water is now in the sample, and the reason the material was freeze-dried in the first place has been partially undone.
Allow the vial to equilibrate in its sealed packaging, typically twenty to thirty minutes for a small vial. Do not accelerate this with heat.
Before opening, check the vial against its documentation: lot number, compound identity, stated quantity. Record the lot number in the laboratory notebook at this point rather than later, because once several vials are open it becomes guesswork.
Lyophilizate is light and static-prone. Centrifuge or tap the vial briefly so any material clinging to the stopper or the vial walls settles to the bottom before the seal is broken. Material lost to the stopper is material missing from the calculation.
Choosing a solvent
Solubility is determined by the sequence, not by preference. The relevant question is the net charge of the peptide at the pH of the intended solvent.
Peptides rich in basic residues such as arginine, lysine and histidine generally dissolve in mildly acidic aqueous solution. Peptides rich in acidic residues such as aspartate and glutamate generally dissolve in mildly basic aqueous solution. Peptides with a high proportion of hydrophobic residues may resist aqueous solvents entirely and require a small volume of an organic co-solvent such as acetonitrile, dimethyl sulfoxide or acetic acid to dissolve first, followed by dilution into the aqueous buffer.
Common laboratory solvents include sterile water, bacteriostatic water containing 0.9% benzyl alcohol as a preservative, dilute acetic acid, and buffered saline. Bacteriostatic water is chosen where a stock solution will be accessed more than once, since the preservative limits microbial growth across repeated openings. Sterile water is appropriate for single-use preparation.
Where a compound has known solubility behavior, that information belongs on the product documentation. Where it does not, the standard approach is a small-scale trial: dissolve a test quantity, observe, and scale from what worked. A trial on a few milligrams costs less than a failed attempt on the whole vial.
Adding the solvent
Solvent should run down the inner wall of the vial rather than being injected directly onto the lyophilizate. A jet of liquid striking the cake directly introduces shear and foaming, and foaming means the peptide is partitioning to the air-liquid interface, where it denatures and aggregates.
Once the solvent is in, the vial should be swirled gently or left to stand. It should not be shaken or vortexed vigorously. Many peptides dissolve on their own within a few minutes given the chance.
If material remains undissolved after gentle agitation, options in order of escalation are a longer standing period, brief sonication in a water bath, or a change of solvent pH. Heat is generally the last resort and is inappropriate for sequences prone to oxidation or deamidation.
A properly reconstituted solution is clear. Cloudiness, visible particulates, or a persistent film usually indicate incomplete dissolution or aggregation, and neither is resolved by proceeding as if the solution were fine.
Concentration
Concentration follows from mass and volume:
Stock concentration
C = m / V
where C is concentration in mg/mL, m is the mass of peptide in mg, and V is the solvent volume in mL.
The mass term is where the error usually enters. The figure on the label is typically the nominal peptide quantity, but the material in the vial also contains water and counterion. Where net peptide content is stated on the certificate of analysis, the corrected mass is:
Corrected peptide mass
m = total lyophilizate mass x (net peptide % / 100)
For work where absolute concentration matters, this correction is not optional. For qualitative work it may not matter. Knowing which situation you are in is the point.
Aliquoting and freeze-thaw
Repeated freezing and thawing is one of the most reliable ways to degrade a peptide solution. Each cycle concentrates solutes at the ice boundary, shifts local pH, and drives aggregation. The damage accumulates and is not visible.
The standard mitigation is to aliquot the stock immediately after reconstitution into single-use volumes, so that each aliquot is thawed exactly once. Aliquots should be labeled with the compound, the lot number, the concentration, the solvent and the date. An unlabeled tube in a freezer becomes waste within a month.
Low-binding polypropylene tubes are generally preferred, as peptides adsorb to glass and to standard plastics, and at low concentrations that adsorption can remove a significant fraction of the material from solution.
Storage conditions
General laboratory practice for stability, in the absence of compound-specific guidance:
- Lyophilized, long term. Minus 20 degrees Celsius or colder, sealed, desiccated, protected from light.
- Lyophilized, short term. Refrigerated or room temperature for brief periods, though cold and dry is always preferable.
- In solution, short term. Two to eight degrees Celsius, for days rather than weeks.
- In solution, longer term. Minus 20 degrees Celsius or colder as single-use aliquots.
- Frost-free freezers. Avoid where possible, since the automatic defrost cycle repeatedly warms the contents.
Sequences containing cysteine, methionine, tryptophan or N-terminal glutamine are more sensitive than average, to oxidation in the first three cases and to cyclization in the last. Where a compound has stated stability data, that data supersedes any general rule, and it belongs on the lot documentation.
Recording what was done
Reconstitution is a step in the experiment, not a preliminary to it. Lot number, solvent, volume, resulting concentration, date, and storage location should all be recorded at the time. When a result later looks anomalous, this record is what distinguishes a real finding from a handling artifact.
All compounds discussed here are supplied for laboratory research use only. They are not medicines, are not for human or veterinary use, and are not for diagnostic or therapeutic application of any kind. The handling practices described are general laboratory technique and are not instructions for preparing any material for administration.

